2-HOBA supplement for pulmonary arterial hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This study tests an investigational supplement called 2-HOBA to see if it can help people with pulmonary arterial hypertension (PAH), a condition that causes high blood pressure in the lungs. It aims to see if 2-HOBA improves exercise ability and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with pulmonary arterial hypertension (PAH) — either the type that runs in families, has no known cause, comes from a heart defect, or is linked to drugs or toxins.
- Your PAH medications have been stable for at least 3 months before starting (small changes like a diuretic dose are okay).
- You are able to walk, even if you need a cane or walker (but not if you are wheelchair-bound or bed-bound).
- You can take aspirin without experiencing breathing problems, asthma, or allergies related to aspirin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called HS235 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. It aims to see if the drug can help improve symptoms and exercise ability.
This trial tests an investigational drug called NS-863 for people with pulmonary arterial hypertension (PAH), a condition of high blood pressure in the lungs. The study aims to see if the drug can improve symptoms and exercise ability.
This trial tests a supervised exercise program for people with pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs. It aims to see if regular exercise can improve your daily function and quality of life.
This study tests whether using a mobile health tool can help people with pulmonary arterial hypertension (PAH) manage their condition in daily life. It’s aimed at adults who are stable on their PAH medicines and can track activity using a wearable device.
This study looks at how pulmonary arterial hypertension (PAH), a type of high blood pressure in the lungs, affects muscle mass and strength. It aims to find ways to help patients maintain muscle and improve their quality of life.
This study tests whether a home-based exercise program, added to your regular medications, can help people who are newly diagnosed with pulmonary arterial hypertension feel better and improve their daily function.
Hear when a new Pulmonary Arterial Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.